India to Kenya: Linagliptin Export Trade Route
India has recorded 25 verified shipments of Linagliptin exported to Kenya, representing a combined trade value of $79.3K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $3.2K USD. The leading Indian exporter is CLAROID PHARMACEUTICALS PRIVATE LIMITED, which accounts for 60% of total export value with 5 shipments worth $47.4K USD. On the buying side, HARLEYS LIMITED is the largest importer in Kenya with $28.9K USD in purchases. The top 3 suppliers — CLAROID PHARMACEUTICALS PRIVATE LIMITED, CLAROID PHARMACEUTICALS LIMITED, PRISM BIO-PHARMA PRIVATE LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Linagliptin corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $79.3K USD. The route is dominated by CLAROID PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's linagliptin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $3.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with linagliptin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #18 among India's top linagliptin export destinations globally.
On the import side, key buyers of Indian linagliptin in Kenya include HARLEYS LIMITED, SKY HEATHCARE LIMITED, C/O SKY HEATHCARE LIMITED and 9 others. HARLEYS LIMITED is the single largest importer with 3 shipments valued at $28.9K USD.
Route Characteristics
- Average transit
